Barclays’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-37,100
Closed -$1.57M 6366
2019
Q4
$1.57M Hold
37,100
﹤0.01% 3239
2019
Q3
$1.55M Hold
37,100
﹤0.01% 3184
2019
Q2
$1.36M Hold
37,100
﹤0.01% 3358
2019
Q1
$1.42M Sell
37,100
-417,400
-92% -$15.5M ﹤0.01% 3006
2018
Q4
$16M Buy
454,500
+137,100
+43% +$4.75M 0.01% 871
2018
Q3
$10.4M Hold
317,400
0.01% 1233
2018
Q2
$9.84M Sell
317,400
-15,800
-5% -$452K 0.01% 1236
2018
Q1
$9.01M Buy
333,200
+103,100
+45% +$2.75M 0.01% 1236
2017
Q4
$6.34M Sell
230,100
-1,209,600
-84% -$34.9M 0.01% 1481
2017
Q3
$45.9M Buy
1,439,700
+1,439,300
+359,825% +$46.1M 0.05% 324
2017
Q2
$13K Sell
400
-100
-20% -$3.31K ﹤0.01% 5968
2017
Q1
$16K Buy
+500
New +$16.1K ﹤0.01% 5904

Other funds holding OHI

Barclays's OHI Position: Q1 2026 in Review

Barclays reduced its Omega Healthcare (OHI) stake by 39% in Q1 2026, selling an estimated $4.94M and leaving 168,608 shares worth $7.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

Barclays first reported a position in OHI in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.3M in Q2 2025. 741 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Barclays held 168,608 shares of Omega Healthcare worth $7.39M as of Q1 2026.
  • Barclays sold 108,134 Omega Healthcare shares in Q1 2026, an estimated $4.94M.
  • Omega Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1606 holding.
  • Barclays first reported a position in Omega Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Omega Healthcare position peaked at $26.3M in Q2 2025.
  • 741 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.